Renal function based on serum cystatin C versus creatinine in determining mortality risk in type 2 diabetes: the Fremantle Diabetes Study Phase II

被引：0
|
作者：
Davis, W. A. [1 ]
Chubb, P. [2 ]
Bruce, D. G. [1 ]
Davis, T. M. E. [1 ]
机构：
[1] Univ Western Australia, Sch Med, Fremantle, WA, Australia
[2] PathWest Lab Med WA, Murdoch, WA, Australia
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
基金：
澳大利亚国家健康与医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
128
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [1] Serum bicarbonate concentration and the risk of death in type 2 diabetes: the Fremantle Diabetes Study Phase II
    S. A. Paul Chubb
    Wendy A. Davis
    Timothy M. E. Davis
    Acta Diabetologica, 2023, 60 : 1333 - 1342
  • [2] Serum bicarbonate concentration and the risk of death in type 2 diabetes: the Fremantle Diabetes Study Phase II
    Chubb, S. A. Paul
    Davis, Wendy A.
    Davis, Timothy M. E.
    ACTA DIABETOLOGICA, 2023, 60 (10) : 1333 - 1342
  • [3] Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
    Shlipak, Michael G.
    Matsushita, Kunihiro
    Arnlov, Johan
    Inker, Lesley A.
    Katz, Ronit
    Polkinghorne, Kevan R.
    Rothenbacher, Dietrich
    Sarnak, Mark J.
    Astor, Brad C.
    Coresh, Josef
    Levey, Andrew S.
    Gansevoort, Ron T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (10): : 932 - 943
  • [4] Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II
    Bruce, David G.
    Davis, Wendy A.
    Davis, Timothy M. E.
    DIABETES OBESITY & METABOLISM, 2018, 20 (12): : 2852 - 2859
  • [5] Lifetime depression and type 2 diabetes: the Fremantle diabetes study phase II
    Davis, W. A.
    Davis, T. M. E.
    Starkstein, S. E.
    Bruce, D. G.
    DIABETOLOGIA, 2012, 55 : S111 - S111
  • [6] Performance of serum cystatin-C versus serum creatinine in subjects with type 1 diabetes
    Buysschaërt, M
    Joudi, H
    Wallemacq, P
    Hermans, MP
    DIABETES CARE, 2003, 26 (04) : 1320 - 1320
  • [7] A contemporary Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study Phase II
    Davis, W. A.
    Hunter, M.
    Davis, T. M. E.
    DIABETOLOGIA, 2018, 61 : S575 - S576
  • [8] ESTIMATING RENAL FUNCTION IN DIABETES: A COMPARISON OF CYSTATIN C AND CREATININE BASED METHODS
    Macisaac, R. I.
    Tsalamandris, C.
    Thomas, M. C.
    Premaratne, E.
    Panagiotopoulos, S.
    Smith, T. J.
    Power, D. A.
    Jerums, G.
    NEPHROLOGY, 2006, 11 : A49 - A49
  • [9] Prevalence and prognosis of a low serum testosterone in men with type 2 diabetes: the Fremantle Diabetes Study Phase II
    Hamilton, Emma J.
    Davis, Wendy A.
    Makepeace, Ashley
    Lim, Ee Mun
    Yeap, Bu B.
    Peters, Kirsten E.
    Davis, Timothy M. E.
    CLINICAL ENDOCRINOLOGY, 2016, 85 (03) : 444 - 452
  • [10] Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
    Peters, Kirsten E.
    Davis, Wendy A.
    Ito, Jun
    Winfield, Kaye
    Stoll, Thomas
    Bringans, Scott D.
    Lipscombe, Richard J.
    Davis, Timothy M. E.
    DIABETES CARE, 2017, 40 (11) : 1548 - 1555
12345